enVVeno Medical Corporation (NVNO) Balance Sheet
NVNO balance sheet, 2025
December 31, 2025 · U.S. dollars$29.6M assets = $2.4M liabilities + $27.1M equity
Both columns are drawn to the same scale: what NVNO owns equals what it owes plus shareholders’ equity. Hover a block for its value.
NVNO financial health
Descriptive bands, not a rating. Fiscal 2025.
NVNO balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $1.8M2016 | $29.6M2025 | +36.6%/yr | |
| Total liabilities | $2.1M2016 | $2.4M2025 | +1.8%/yr | |
| Shareholders’ equity | −$4.2M2016 | $27.1M2025 | — | |
| Cash & short-term investments | $56,5142016 | $28.2M2025 | +99.4%/yr | |
| Total debt | $632,7722016 | $700,0002025 | +1.1%/yr | |
| Net cash (debt) | −$576,2582016 | $27.5M2025 | +$28.1M | |
| Working capital | −$1.7M2016 | $26.7M2025 | +$28.4M | |
| Debt / equity | 0.012018 | 0.032025 | +0.01 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
NVNO assets
NVNO liabilities and equity
NVNO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
NVNO balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $28.2M | $43.2M | $46.4M | $39.0M | $54.7M | $9.3M | $1.3M | $2.7M | $77,688 | $56,514 |
| Cash & equivalents | $3.1M | $1.8M | $3.6M | $4.6M | $54.7M | $9.3M | $1.3M | $2.7M | $77,688 | $56,514 |
| Short-term investments | $25.1M | $41.4M | $42.8M | $34.5M | $0 | — | — | — | — | — |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $32,022 | $35,181 | $199,750 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $90,908 |
| Other current assets | $614,000 | $581,000 | $511,000 | $392,000 | $312,350 | $234,467 | $116,647 | $64,306 | $57,544 | $46,049 |
| Total current assets | $28.8M | $43.7M | $46.9M | $39.4M | $55.0M | $9.6M | $1.4M | $2.8M | $170,413 | $393,221 |
| Property, plant & equipment (net) | $705,000 | $1.2M | $1.7M | $2.2M | $2.6M | $938,941 | $1.2M | $26,153 | $23,843 | $28,810 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $666,467 | $1.1M | $1.2M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $31,000 | $31,000 | $31,000 | $31,000 | $54,493 | $29,843 | $839,898 | $29,843 | $911,222 | $128,118 |
| Total assets | $29.6M | $45.0M | $48.6M | $41.7M | $57.7M | $10.5M | $3.4M | $3.6M | $2.2M | $1.8M |
| Liabilities | ||||||||||
| Accounts payable | $358,000 | $1.0M | $427,000 | $648,000 | $560,083 | $1.4M | $1.2M | $1.1M | $1.5M | $541,957 |
| Short-term debt | $390,000 | $364,000 | $338,000 | $314,000 | $291,000 | $626,902 | $288,685 | $26,985 | $2.6M | $632,772 |
| Deferred revenue | — | — | −$427,000 | — | $668,826 | $33,000 | $33,000 | $33,000 | $103,400 | $11,951 |
| Total current liabilities | $2.1M | $2.1M | $1.4M | $1.5M | $1.6M | $3.2M | $1.9M | $1.5M | $8.2M | $2.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $700,000 | $1.1M | $1.4M | $1.7M | $2.0M | $567,948 | $856,633 | — | — | — |
| Other long-term liabilities | $310,000 | $699,999 | $1.1M | $1.4M | $1.7M | $253,746 | $567,947 | $33,000 | $3.2M | $551,350 |
| Total liabilities | $2.4M | $2.8M | $2.4M | $2.9M | $3.3M | $3.4M | $2.4M | $1.5M | $8.2M | $2.1M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | — | — | — | — | $95 | $25 | $179 | $117 | $61 | $122 |
| Retained earnings (deficit) | −$171.3M | −$151.9M | −$130.0M | −$106.5M | −$81.9M | −$65.3M | −$56.2M | −$48.6M | −$35.5M | −$27.7M |
| Accumulated other comprehensive income | — | — | — | — | — | $0 | — | — | −$5.2M | −$3.9M |
| Total shareholders' equity | $27.1M | $42.2M | $46.2M | $38.7M | $54.4M | $7.1M | $989,940 | $2.0M | −$11.1M | −$4.2M |
| Key figures | ||||||||||
| Total debt | $700,000 | $1.1M | $1.4M | $1.7M | $2.0M | $880,648 | $856,633 | $26,985 | $2.6M | $632,772 |
| Net cash (debt) | $27.5M | $42.1M | $45.0M | $37.3M | $52.7M | $8.5M | $450,598 | $2.7M | −$2.5M | −$576,258 |
| Working capital | $26.7M | $41.6M | $45.6M | $37.9M | $53.5M | $6.4M | −$452,434 | $1.3M | −$8.0M | −$1.7M |
| Tangible book value | $27.1M | $42.2M | $46.2M | $38.7M | $54.4M | $7.1M | $989,940 | $1.4M | −$12.2M | −$5.5M |
| Book value per share | $46.06 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 589K | — | — | — | — | — | — | — | — | — |
| Current ratio | 13.58 | 20.88 | 34.23 | 25.78 | 34.83 | 3.00 | 0.76 | 1.86 | 0.02 | 0.19 |
| Quick ratio | 13.30 | 20.60 | 33.85 | 25.52 | 34.64 | 2.93 | 0.70 | 1.82 | 0.01 | 0.12 |
| Debt / equity | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.12 | 0.87 | 0.01 | — | — |
| Equity / assets | 91.8% | 93.8% | 95.0% | 93.0% | 94.3% | 67.4% | 28.8% | 57.2% | −502.5% | −236.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $21.5M | $24.9M | $28.2M | $31.0M | $35.1M | $38.9M | $43.2M | $48.4M | $39.1M | $42.9M | $46.4M | $25.7M |
| Cash & equivalents | $2.8M | $2.6M | $3.1M | $1.5M | $2.0M | $2.9M | $1.8M | $17.9M | $2.4M | $2.3M | $3.6M | $4.9M |
| Short-term investments | $18.6M | $22.3M | $25.1M | $29.4M | $33.1M | $36.0M | $41.4M | $30.5M | $36.7M | $40.6M | $42.8M | $20.8M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $596,000 | $559,000 | $614,000 | $547,000 | $462,000 | $538,000 | $581,000 | $672,000 | $469,000 | $306,000 | $511,000 | $520,000 |
| Total current assets | $22.1M | $25.5M | $28.8M | $31.5M | $35.6M | $39.5M | $43.7M | $49.1M | $39.5M | $43.2M | $46.9M | $26.2M |
| Property, plant & equipment (net) | $547,000 | $577,000 | $705,000 | $822,000 | $942,000 | $1.1M | $1.2M | $1.3M | $1.4M | $1.6M | $1.7M | $1.8M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $31,000 | $31,000 | $31,000 | $31,000 | $31,000 | $31,000 | $31,000 | $31,000 | $31,000 | $31,000 | $31,000 | $66,000 |
| Total assets | $22.7M | $26.1M | $29.6M | $32.4M | $36.6M | $40.6M | $45.0M | $50.4M | $41.0M | $44.8M | $48.6M | $28.1M |
| Liabilities | ||||||||||||
| Accounts payable | $540,000 | $813,000 | $358,000 | $626,000 | $1.1M | $703,000 | $1.0M | $894,000 | $698,000 | $604,000 | $427,000 | $1.2M |
| Short-term debt | $402,000 | $396,000 | $390,000 | $286,000 | $377,000 | $370,000 | $364,000 | $357,000 | $351,000 | $344,000 | $338,000 | $331,000 |
| Deferred revenue | — | — | — | — | — | — | — | −$894,000 | — | — | −$427,000 | −$1.2M |
| Total current liabilities | $1.9M | $2.1M | $2.1M | $2.4M | $3.0M | $1.7M | $2.1M | $2.2M | $1.7M | $1.5M | $1.4M | $2.0M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $505,000 | $603,000 | $700,000 | $791,000 | $882,000 | $979,000 | $1.1M | $1.1M | $1.2M | $1.3M | $1.4M | $1.5M |
| Other long-term liabilities | $103,000 | $207,000 | $310,000 | $504,999 | $504,999 | $609,000 | $699,999 | $790,999 | $881,999 | $972,999 | $1.1M | $1.1M |
| Total liabilities | $2.0M | $2.4M | $2.4M | $2.9M | $3.5M | $2.3M | $2.8M | $3.0M | $2.6M | $2.5M | $2.4M | $3.2M |
| Shareholders' equity | ||||||||||||
| Retained earnings (deficit) | −$178.8M | −$175.2M | −$171.3M | −$167.6M | −$163.1M | −$156.4M | −$151.9M | −$145.6M | −$140.0M | −$135.0M | −$130.0M | −$124.4M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | $0 | — | — | — |
| Total shareholders' equity | $20.7M | $23.7M | $27.1M | $29.4M | $33.1M | $38.3M | $42.2M | $47.4M | $38.4M | $42.4M | $46.2M | $24.9M |
| Key figures | ||||||||||||
| Total debt | $505,000 | $603,000 | $700,000 | $791,000 | $882,000 | $979,000 | $1.1M | $1.1M | $1.2M | $1.3M | $1.4M | $1.5M |
| Net cash (debt) | $21.0M | $24.3M | $27.5M | $30.2M | $34.3M | $38.0M | $42.1M | $47.2M | $37.8M | $41.6M | $45.0M | $24.2M |
| Working capital | $20.2M | $23.3M | $26.7M | $29.1M | $32.6M | $37.8M | $41.6M | $46.8M | $37.8M | $41.8M | $45.6M | $24.2M |
| Tangible book value | $20.7M | $23.7M | $27.1M | $29.4M | $33.1M | $38.3M | $42.2M | $47.4M | $38.4M | $42.4M | $46.2M | $24.9M |
| Book value per share | $30.80 | $36.31 | — | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 671K | 654K | — | — | — | — | — | — | — | — | — | — |
| Current ratio | 11.70 | 11.89 | 13.58 | 13.12 | 11.81 | 23.77 | 20.88 | 22.01 | 23.33 | 29.08 | 34.23 | 12.91 |
| Quick ratio | 11.39 | 11.63 | 13.30 | 12.90 | 11.66 | 23.44 | 20.60 | 21.70 | 23.05 | 28.88 | 33.85 | 12.65 |
| Debt / equity | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.06 |
| Equity / assets | 91.2% | 91.0% | 91.8% | 91.0% | 90.4% | 94.4% | 93.8% | 94.0% | 93.7% | 94.5% | 95.0% | 88.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 26, 2026); data from EODHD.
NVNO financial position
At the end of fiscal 2025 (December 31, 2025), enVVeno Medical had total assets of $29.6 million (down 34.2% from a year earlier), total liabilities of $2.4 million and shareholders' equity of $27.1 million. It held $28.2 million in cash and short-term investments against $0.7 million of debt, a net cash position of $27.5 million. Its current ratio was 13.58. In the latest quarter (ended June 30, 2026) total assets were $22.7 million and equity $20.7 million.
Related: NVNO income statement, NVNO cash flow statement, NVNO key metrics. See the NVNO stock overview for the latest quote and news.
NVNO balance sheet FAQ
What are enVVeno Medical's total assets?
enVVeno Medical reported total assets of $29.6 million at the end of fiscal 2025 (December 31, 2025), compared with $45.0 million a year earlier.
How much debt does enVVeno Medical have?
enVVeno Medical had $0.7 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.03.
How much cash does enVVeno Medical have?
enVVeno Medical held $28.2 million in cash and short-term investments at the end of fiscal 2025; with $0.7 million of debt that is net cash of $27.5 million.
What is enVVeno Medical's book value?
enVVeno Medical's shareholders' equity (book value) was $27.1 million at the end of fiscal 2025, or $46.06 per share.
What is enVVeno Medical's current ratio?
enVVeno Medical had current assets of $28.8 million and current liabilities of $2.1 million, a current ratio of 13.58 (it can cover its short-term obligations).